EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

ONCOLOGIC RESULTS OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN TREATMENT OF ASCITES TYPE OF OVARIAN CANCER (ATOC) (RESIDUAL, METASTASIS)

*D. A. Sulaymonov, A. N. Abdikhakimov, A. I. Khasanov and U. A. Boratov

ABSTRACT

Ovarian cancer (OC) has one of the leading positions among oncogynecological diseases and is increasing year by year. This disease occupies the 11th place in the structure of oncological diseases of the Republic of Uzbekistan (according to the State Statistical Committee 's data for 2017), and the 3rd place with sexual transmitted diseases among women, disease rate is 2.0 per 100,000 population and mortality rate is 30%. Since the statistical data is a concern, problems with the treatment of this pathology remain topical. Another reason for the incidence of ovarian cancer is detecting it late. In 75-80% of the cases, the disease is detected in the III-IV stage, in 52% of the cases, the tumor goes out of the organs and spreads in the abdominal cavity, whereas the 5-year survival does not exceed 10-20%.[2,5]

Keywords: .

[Full Text Article] [Download Certificate]